Celanese Discusses Innovative Uses for EVA Polymers at AAPS

Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will be discussing novel applications in pharmaceuticals and medical devices for ethylene vinyl acetate (EVA) polymers during AAPS 2014 in San Diego, California.

At the AAPS annual meeting and expo, Celanese will meet with leaders in the pharmaceutical and medical industries to discuss potential uses of EVA in two ways: as controlled release of drugs for oral administration, and EVA as a foamed excipient to deliver stem cells, growth factors and biologics.

“EVA polymers have a successful history in the pharmaceutical industry as a parenteral controlled release excipient,” said Don Loveday, healthcare and life sciences leader for Celanese. “We believe these two routes of administration offer incredible potential to the medical world.”

EVA in oral applications

The Celanese whitepaper entitled Potential Use of Ethylene Vinyl Acetate Copolymer Excipients in Oral Controlled Release Applications: A Literature Review summarizes the recent developments of EVA-based oral controlled release drug delivery systems. Fifty separate references are cited in this comprehensive paper.

EVA as a foamed excipient

In the Celanese whitepaper entitled EVA Foamed Excipient: Novel Way to Deliver Stem Cells, Growth Factors and Biologics for Controlled Release Applications, the controlled release delivery of therapeutic agents to prevent recurrence of brain tumors following resection was posited. In this study, high molecular weight simulated agents (70,000 and 200,000 Dalton polystyrene sulfonate - PSS) demonstrated controlled release delivery for more than 200 hours. More research is planned in this arena.

Technical, marketing and sales teams will be available at the Celanese booth #1150 at the AAPS expo to discuss the various uses of EVA polymers for controlled release. To set up a meeting at the expo, please contact Don Loveday at vitaldose@celanese.com or to learn more, visit www.celanese.com/Tradeshows/AAPS-2014.aspx.

About Celanese

Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. With sales almost equally divided between North America, Europe and Asia, the company uses the full breadth of its global chemistry, technology and business expertise to create value for customers and the corporation. Celanese partners with customers to solve their most critical needs while making a positive impact on its communities and the world. Based in Dallas, Texas, Celanese employs approximately 7,400 employees worldwide and had 2013 net sales of $6.5 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com or our blog at www.celaneseblog.com.

All trademarks indicated above are owned by Celanese International Corporation or its affiliates.

Forward-Looking Statements

This release may contain “forward-looking statements,” which include information concerning the company's plans, products, objectives, goals, strategies, future revenues or performance, capital expenditures, and other information that is not historical information. When used in this release, the words “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “may,” “can,” “could,” “would,” “might,” “will” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company or its customers will realize these benefits or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release. These risks and uncertainties include, among other things: changes in general economic, business, political and regulatory conditions; changes in the price and availability of raw materials; the introduction of competing products by other companies; market acceptance of our products; changes in the degree of intellectual property and other legal protection afforded to our products and processes; the impact of technological developments and competition; adoption of new or different industry or regulatory standards; unanticipated operational or commercial difficulties, including failure of facilities or processes or products to be designed or constructed, or to operate, in accordance with specifications or expectations; the ability to achieve and maintain plant utilization; ability of third parties, including our commercial partners, suppliers or others, to comply with their commitments to us; increased costs under existing or future environmental regulations, including those relating to climate change; potential liability resulting from pending or future litigation, or from changes in the laws, regulations or policies of governments or other governmental activities in the countries in which we operate; and various other factors discussed from time to time in the company's filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.